全文获取类型
收费全文 | 7255篇 |
免费 | 350篇 |
国内免费 | 169篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 59篇 |
妇产科学 | 148篇 |
基础医学 | 1038篇 |
口腔科学 | 160篇 |
临床医学 | 719篇 |
内科学 | 710篇 |
皮肤病学 | 141篇 |
神经病学 | 531篇 |
特种医学 | 355篇 |
外科学 | 490篇 |
综合类 | 1008篇 |
预防医学 | 655篇 |
眼科学 | 83篇 |
药学 | 1090篇 |
1篇 | |
中国医学 | 311篇 |
肿瘤学 | 230篇 |
出版年
2023年 | 51篇 |
2022年 | 135篇 |
2021年 | 171篇 |
2020年 | 148篇 |
2019年 | 195篇 |
2018年 | 152篇 |
2017年 | 150篇 |
2016年 | 163篇 |
2015年 | 169篇 |
2014年 | 358篇 |
2013年 | 428篇 |
2012年 | 422篇 |
2011年 | 516篇 |
2010年 | 359篇 |
2009年 | 352篇 |
2008年 | 332篇 |
2007年 | 381篇 |
2006年 | 306篇 |
2005年 | 283篇 |
2004年 | 257篇 |
2003年 | 258篇 |
2002年 | 200篇 |
2001年 | 176篇 |
2000年 | 164篇 |
1999年 | 106篇 |
1998年 | 79篇 |
1997年 | 93篇 |
1996年 | 103篇 |
1995年 | 89篇 |
1994年 | 93篇 |
1993年 | 75篇 |
1992年 | 61篇 |
1991年 | 58篇 |
1990年 | 52篇 |
1989年 | 48篇 |
1988年 | 48篇 |
1987年 | 43篇 |
1986年 | 37篇 |
1985年 | 119篇 |
1984年 | 101篇 |
1983年 | 69篇 |
1982年 | 87篇 |
1981年 | 63篇 |
1980年 | 57篇 |
1979年 | 39篇 |
1978年 | 32篇 |
1977年 | 17篇 |
1976年 | 14篇 |
1973年 | 13篇 |
1972年 | 11篇 |
排序方式: 共有7774条查询结果,搜索用时 15 毫秒
1.
《Vaccine》2021,39(45):6601-6613
AKS-452 is a biologically-engineered vaccine comprising an Fc fusion protein of the SARS-CoV-2 viral spike protein receptor binding domain antigen (Ag) and human IgG1 Fc (SP/RBD-Fc) in clinical development for the induction and augmentation of neutralizing IgG titers against SARS-CoV-2 viral infection to address the COVID-19 pandemic. The Fc moiety is designed to enhance immunogenicity by increasing uptake via Fc-receptors (FcγR) on Ag-presenting cells (APCs) and prolonging exposure due to neonatal Fc receptor (FcRn) recycling. AKS-452 induced approximately 20-fold greater neutralizing IgG titers in mice relative to those induced by SP/RBD without the Fc moiety and induced comparable long-term neutralizing titers with a single dose vs. two doses. To further enhance immunogenicity, AKS-452 was evaluated in formulations containing a panel of adjuvants in which the water-in-oil adjuvant, Montanide™ ISA 720, enhanced neutralizing IgG titers by approximately 7-fold after one and two doses in mice, including the neutralization of live SARS-CoV-2 virus infection of VERO-E6 cells. Furthermore, ISA 720-adjuvanted AKS-452 was immunogenic in rabbits and non-human primates (NHPs) and protected from infection and clinical symptoms with live SARS-CoV-2 virus in NHPs (USA-WA1/2020 viral strain) and the K18 human ACE2-trangenic (K18-huACE2-Tg) mouse (South African B.1.351 viral variant). These preclinical studies support the initiation of Phase I clinical studies with adjuvanted AKS-452 with the expectation that this room-temperature stable, Fc-fusion subunit vaccine can be rapidly and inexpensively manufactured to provide billions of doses per year especially in regions where the cold-chain is difficult to maintain. 相似文献
2.
《Vaccine》2019,37(47):6987-6995
Vero cells are nowadays widely used in the production of human vaccines. They are considered as one of the most productive and flexible continuous cell lines available for vaccine manufacturing. However, these cells are anchorage dependent, which greatly complicates upstream processing and process scale-up. Moreover, there is a recognized need to reduce the costs of vaccine manufacturing to develop vaccines that are affordable worldwide. The use of cell lines adapted to suspension growth contributes to reach this objective.The current work describes the adaptation of Vero cells to suspension culture in different serum free media according to multiple protocols based on subsequent passages. The best one that relies on cell adaption to IPT-AFM an in-house developed animal component free medium was then chosen for further studies. Besides, as aggregates have been observed, the improvement of IPT-AFM composition and mechanical dissociation were also investigated.In addition to IPT-AFM, three chemically defined media (CD293, Hycell CHO and CD-U5) and two serum free media (293SFMII and SFM4CHO) were tested to set up a serum free culture of the suspension-adapted Vero cells (VeroS) in shake flasks. Cell density levels higher than 2 × 106 cells/mL were obtained in the assessed conditions. The results were comparable to those obtained in spinner culture of adherent Vero cells grown on Cytodex 1 microcarriers.Cell infection with LP-2061 rabies virus strain at an MOI (Multiplicity of Infection) of 0.1 and a cell density of 8 ± 0.5 × 105 cells/mL resulted in a virus titer higher than 107 FFU/mL in all media tested. Nevertheless, the highest titer equal to 5.2 ± 0.5 × 107 FFU/mL, was achieved in IPT-AFM containing a reduced amount of Ca++ and Mg++. Our results demonstrate the suitability of the obtained VeroS cells to produce rabies virus at a high titer, and pave the way to develop VeroS cells bioreactor process for rabies vaccine production. 相似文献
3.
瘙痒是皮肤科的一种常见症状,是多因素相互作用的结果,其发生受到中枢和外周机制的双重调控,但具体发生机制尚不十分清楚。近年来随着研究的不断深入,多种物质如组胺、乙酰胆碱、5-羟色胺、蛋白酶和蛋白酶相关受体、细胞因子、阿片样肽等介质在瘙痒产生过程中起重要作用,这些介质通过刺激C类神经纤维或直接与皮肤感觉神经纤维受体相结合来介导瘙痒。本文就将皮肤瘙痒的神经传导及传导介质作一综述。 相似文献
4.
雷波 《中国脊柱脊髓杂志》2006,(6)
通过对影响杆菌肽抑菌圈大小的各种因素的研究,从而得到提高地衣芽抱杆菌发酵杆菌肽的产量及测量的最佳效果。研究结果表明豆芽汁培养基发酵的杆菌肽产量最高,并且在豆芽汁中加糖量为2g/dL时,抑菌圈最大。管碟法测定时,培养基的厚度影响最为显著,下层厚度10mL,上层5mL最佳,上层培养基的酸碱度为7.0,指示菌的浓度在10^8cfu/mL时,抑菌圈最清晰,直径最大,平均直径为2.52cm。 相似文献
5.
慢性肺心病哮喘持续状态218例临床分析 总被引:1,自引:0,他引:1
目的探索治疗慢性肺心病哮喘持续状态的方法。方法回顾性分析1983年10月~2005年3月收治的218例慢性肺心病哮喘持续状态患者的临床资料。结果哮喘持续状态在48h以内被控制的62例(28.4%);在72h以内控制的56例(25.7%);在120h以内控制的25例(11.5%);在168h以内控制的34例(15.6%);痊愈出院177例(81.2%);死亡41例(18.8%)。结论(1)治疗慢性肺心病哮喘持续状态.根据患者的病理变化.综合治疗.效果显著。(2)在治疗过程中.要恰当选择抗生素和平喘药;对那些血液黏滞度增高的患者.要加用血液稀释疗法。(3)测定血液黏滞度和氧饱和度.可以指导治疗、估计预后.应当列为常规检查。 相似文献
6.
氟苯咪唑(Fludendazole)由Gelder于1969年合成,直到最近几年才受到各国重视,我国于1983年也合成了该化合物。该药经临床应用疗效显著,抗虫效力高,抗虫谱 相似文献
7.
兔精原干细胞培养及生物学特征的初步研究 总被引:2,自引:0,他引:2
目的:建立精原干细胞的培养方法并对培养细胞的生物学特征进行研究.方法:用饲养层和无饲养层两种方法培养幼家兔精原干细胞,在倒置相差显微镜下观察培养细胞的生长和形态变化,并对细胞的糖原、脂质及c-kit受体的细胞化学和免疫细胞化学染色结果进行分析.结果:成功的分离并培养幼家兔精原干细胞.在培养细胞中精原干细胞为主体细胞,并可见少量间质细胞.根据精原干细胞体积大小和形态特点,可分为大、小两种类型.PAS染色,精原干细胞胞质呈阳性反应;免疫细胞化学染色显示,体积较小的精原干细胞c-kit受体呈强阳性反应,体积较大的大精原干细胞呈弱阳性反应;间质细胞PAS染色和c-kit受体染色呈阴性反应,而脂质染色呈强阳性反应.精原干细胞培养无论有无饲养层,均能呈集落状生长,但有饲养层的培养,细胞的生长明显优于无饲养层培养.结论:青春期前的睾丸生精小管是精原干细胞最集中、数量最多,且容易获取分离的部位;精原干细胞的成功培养为今后重建完整的生精细胞系的治疗性移植和对这类定向干细胞的发育及分化潜能的研究提供了细胞模型. 相似文献
8.
We investigated the clinical background of patients at Shin-Kokura Hospital who showed a positive culture of pleural effusion
during the period from January 1998 through December 2002. Microorganism cultures of the pleural effusions of 127 patients
were performed in this 5-year period. Seventeen patients showed a positive microorganism culture from a pleural effusion,
and 12 of these patients (70.6%) were 60 years old or more. Ten patients were diagnosed with thoracic empyema. Thirteen patients
had an underlying disease such as malignancy (5 cases), diabetes mellitus (4 cases), etc. A purulent effusion and a high concentration
of lactic dehydrogenase (LDH) in the pleural fluid were more frequently recognized in the positive-culture group. A total
of 21 strains of microorganism were isolated from the 17 patients, including 10 strains of Gram-positive cocci, 6 strains
of Gram-negative bacilli, 3 strains of anaerobes, 1 strain of mycobacterium (Mycobacterium tuberculosis), and 1 strain of fungus. Susceptibility to antimicrobial agents was generally good for most of the microorganisms isolated.
Of the 17 patients, chest-tube drainage was performed in 13, and 6 needed a surgical operation. Twelve patients improved,
but 5 died. In this study, thoracic empyema accounted for 58.8% of the 17 cases with a positive culture of pleural effusion.
Of the 10 thoracic empyema patients, 5 patients needed surgical treatment in spite of adequate antimicrobial treatment and
chest-tube drainage. Our data indicate that thoracic empyema is still difficult to treat, and thus adequate and rapid treatment
is needed for any pleural infection. 相似文献
9.
10.
We tested whether hypoglycemia, like hypoxia, would preferentially destroy GABAergic nerve cells in the neocortex. To this end, rat neocortex explants dissected from 6-day-old rat pups and cultured up to a developmental stage approximately comparable to that of the newborn human neocortex, were exposed to hypoglycemia for different periods. Quantitative light microscopic and immunocytochemical evaluation of the cultures demonstrated that hypoglycemia does not preferentially destroy GABAergic but rather non-GABAergic neurons, a finding quite opposite to what was found after hypoxia. Recent biochemical data from other laboratories which seem to support this difference in neuronal vulnerability are discussed. It is concluded that perinatal hypoglycemia may not form such a serious threat with respect to the genesis of epilepsy as does hypoxia. 相似文献